{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:40:16Z","timestamp":1764402016380,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972371"],"award-info":[{"award-number":["81972371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.trsl.2023.10.006","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:07:19Z","timestamp":1698728839000},"page":"26-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Novel MSH2 and TSC2 variants in a Chinese family with Lynch syndrome and their synergistic impact in urothelial carcinoma"],"prefix":"10.1016","volume":"265","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9206-5584","authenticated-orcid":false,"given":"Mingyang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingjian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chungang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3674-0081","authenticated-orcid":false,"given":"Haitao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.trsl.2023.10.006_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174102","article-title":"Lynch syndrome: from carcinogenesis to prevention interventions","volume":"14","author":"Gambini","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.trsl.2023.10.006_bib0002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13053-022-00240-2","article-title":"Modifier genes and Lynch syndrome: some considerations","volume":"20","author":"Scott","year":"2022","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.trsl.2023.10.006_bib0003","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.dnarep.2015.11.025","article-title":"Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancer","volume":"38","author":"Heinen","year":"2016","journal-title":"DNA Repair"},{"issue":"2","key":"10.1016\/j.trsl.2023.10.006_bib0004","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.gastro.2014.04.001","article-title":"Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US multi-society task force on colorectal cancer","volume":"147","author":"Giardiello","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2023.10.006_bib0005","doi-asserted-by":"crossref","unstructured":"Peltom\u00e4ki P.; Vasen H.. Mutations associated with HNPCC predisposition\u2013update of ICG-HNPCC\/INSiGHT mutation database. Dis Markers, 2004, 20.4-5: 269-276.","DOI":"10.1155\/2004\/305058"},{"issue":"2","key":"10.1016\/j.trsl.2023.10.006_bib0006","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes","volume":"110","author":"Syngal","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.trsl.2023.10.006_bib0007","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jamadermatol.2014.1217","article-title":"Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm","volume":"150","author":"Everett","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.trsl.2023.10.006_bib0008","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10689-015-9782-3","article-title":"Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome","volume":"14","author":"Lamba","year":"2015","journal-title":"Fam Cancer"},{"key":"10.1016\/j.trsl.2023.10.006_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2015.10.005","article-title":"Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome","volume":"49","author":"Jessup","year":"2016","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.trsl.2023.10.006_bib0010","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.urology.2015.08.018","article-title":"Urinary tract cancer in Lynch syndrome; increased risk in carriers of MSH2 mutations","volume":"86","author":"Joost","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.trsl.2023.10.006_bib0011","doi-asserted-by":"crossref","first-page":"E584","DOI":"10.1111\/j.1464-410X.2012.11298.x","article-title":"A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool","volume":"110","author":"Audenet","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.trsl.2023.10.006_bib0012","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MOU.0000000000000340","article-title":"Lynch syndrome in upper tract urothelial carcinoma: significance, screening, and surveillance","volume":"27","author":"Pradere","year":"2017","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.trsl.2023.10.006_bib0013","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.juro.2017.08.002","article-title":"Universal point of care testing for Lynch syndrome in patients with upper tract urothelial carcinoma","volume":"199","author":"Metcalfe","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.trsl.2023.10.006_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.774202","article-title":"Identification of germline mutations in upper tract urothelial carcinoma with suspected lynch syndrome","volume":"12","author":"Guan","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.trsl.2023.10.006_bib0015","unstructured":"Davison K.M.. Pathogenic mutations and novel variants in MLH1 and MSH2 in a South African colon cancer cohort."},{"issue":"13","key":"10.1016\/j.trsl.2023.10.006_bib0016","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.trsl.2023.10.006_bib0017","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/humu.20735","article-title":"Accurate classification of MLH1\/MSH2 missense variants with multivariate analysis of protein polymorphisms\u2013mismatch repair (MAPP-MMR)","volume":"29","author":"Chao","year":"2008","journal-title":"Hum Mutat"},{"issue":"12","key":"10.1016\/j.trsl.2023.10.006_bib0018","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/s41379-018-0058-y","article-title":"Two-stain immunohistochemical screening for Lynch syndrome in colorectal cancer may fail to detect mismatch repair deficiency","volume":"31","author":"Pearlman","year":"2018","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.trsl.2023.10.006_bib0019","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.eururo.2018.10.040","article-title":"A whole-genome CRISPR screen identifies a role of MSH2 in cisplatin-mediated cell death in muscle-invasive bladder cancer","volume":"75","author":"Goodspeed","year":"2019","journal-title":"Eur Urol"},{"issue":"2 Pt 1","key":"10.1016\/j.trsl.2023.10.006_bib0020","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.ju.0000074621.74361.10","article-title":"Human bladder tumors with 2-hit mutations of tumor suppressor gene TSC1 and decreased expression of p27","volume":"170","author":"Adachi","year":"2003","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.trsl.2023.10.006_bib0021","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.euo.2021.11.001","article-title":"Upper tract urothelial carcinoma in the lynch syndrome Tumour spectrum: a comprehensive overview from the European association of urology - young academic urologists and the global society of rare genitourinary tumors","author":"Lonati","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.trsl.2023.10.006_bib0022","article-title":"The role of TSC2 in breast cancer: a literature review","volume":"13","author":"Zhu","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.trsl.2023.10.006_bib0023","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-15-2631","article-title":"Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic renal cell carcinoma","volume":"22","author":"Kwiatkowski","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.trsl.2023.10.006_bib0024","article-title":"Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: a multi-center real-world retrospective study","volume":"3","author":"Hu","year":"2022","journal-title":"Cell Rep Med"},{"issue":"8","key":"10.1016\/j.trsl.2023.10.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207155","article-title":"BCAT2 Shapes a noninflamed tumor microenvironment and induces resistance to anti-PD-1\/PD-L1 immunotherapy by negatively regulating proinflammatory chemokines and anticancer immunity","volume":"10","author":"Cai","year":"2023","journal-title":"Adv Sci"},{"issue":"25","key":"10.1016\/j.trsl.2023.10.006_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300110","article-title":"S100A5 attenuates efficiency of anti-PD-L1\/PD-1 immunotherapy by inhibiting CD8+ T cell-mediated anti-cancer immunity in bladder carcinoma","volume":"10","author":"Li","year":"2023","journal-title":"Adv Sci"},{"issue":"1","key":"10.1016\/j.trsl.2023.10.006_bib0027","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12916-021-02163-6","article-title":"5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer","volume":"19","author":"Hu","year":"2021","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.trsl.2023.10.006_bib0028","doi-asserted-by":"crossref","first-page":"e98674","DOI":"10.1172\/jci.insight.98674","article-title":"TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1\/anti-CTLA-4 immunotherapy","volume":"3","author":"Liu","year":"2018","journal-title":"JCI Insight"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423001792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423001792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:49:38Z","timestamp":1761828578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524423001792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":28,"alternative-id":["S1931524423001792"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2023.10.006","relation":{},"ISSN":["1931-5244"],"issn-type":[{"type":"print","value":"1931-5244"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel MSH2 and TSC2 variants in a Chinese family with Lynch syndrome and their synergistic impact in urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2023.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}